French artist Camille Walala hosts “Planet Walala” Colourful Public Art Show at Harbour City, the No.1 Shopping Mall in Hong Kong, with the first-ever Hong Kong City Sign, outdoor artistic maze and solo art exhibition

HONG KONG, March 21, 2024 /PRNewswire/ — Harbour City, Hong Kong’s premier shopping mall is delighted to present the striking Colourful Public Art Show “Planet Walala @Harbour City” from 21 March to 21 April, during Hong Kong Arts Month. Created by the renowned French artist Camille Walala, the project features two expansive public installations and a […]

Compute for Climate Fellowship Announces Inaugural Winners and Opens Applications for 2024

The program funds proof of concepts for new ideas leveraging advanced cloud computing, including generative AI and high-performance computing, to solve some of the biggest challenges in the fight against climate change LJUBLJANA, Slovenia, March 21, 2024 /PRNewswire/ — The International Research Centre on Artificial Intelligence (IRCAI), an organization under the auspices of UNESCO, and Amazon Web […]

Henlius 2023 Annual Results: Revenue surpassed RMB5.39 billion with a net profit RMB546 million, first full-year profitability achieved

SHANGHAI, March 21, 2024 /PRNewswire/ — Henlius (2696.HK) announced its 2023 annual results. During the reporting period, Henlius’ revenue reached about RMB5.3949 billion, representing an increase of 67.8% YoY, and recorded a net profit of RMB546.0 million. This is the first time for Henlius to achieve full-year profits following the company’s achievement of its first half-year […]

Borderless AI Launches from Stealth with $27M Investment to Bring World’s First AI Agent to HR Space

The company is building AI agents for the global HR industry, leveraging conversational AI to automate and speed up the process of on-boarding, managing, and paying international team members. TORONTO, March 21, 2024 /PRNewswire/ — Borderless AI, the AI-powered startup disrupting the Employer of Record (EOR) space, today announced that it has raised $27 million […]

Compute for Climate Fellowship Announces Inaugural Winners and Opens Applications for 2024

The program funds proof of concepts for new ideas leveraging advanced cloud computing, including generative AI and high-performance computing, to solve some of the biggest challenges in the fight against climate change LJUBLJANA, Slovenia, March 21, 2024 /PRNewswire/ — The International Research Centre on Artificial Intelligence (IRCAI), an organization under the auspices of UNESCO, and Amazon Web […]

FDA Grants Orphan Drug Designation to Cevidoplenib for ITP

PANGYO, South Korea, March 21, 2024 /PRNewswire/ — Oscotec Inc. has secured orphan drug designation (ODD) from the U.S. Food and Drug Administration (FDA) for its SYK inhibitor, Cevidoplenib, to treat immune thrombocytopenia (ITP). Oscotec has successfully completed phase 2 study in patients with chronic ITP last year and are currently seeking partners for further […]

Aireon Signs Expanded Data Distribution Deal with Airbus for Space-Based ADS-B

MCLEAN, Va., March 21, 2024 /PRNewswire/ — Aireon, the leader in space-based air traffic management data products and services, has signed an expanded distribution agreement with Airbus to enable more users access to the Aireon’s space-based automatic dependent surveillance-broadcast (ADS-B) data. Under the terms of the multi-year contract, Airbus will integrate Aireon’s global ADS-B data […]

Yeahka Announces 2023 Annual Results

Brilliant growth momentum in one-stop payment services, GPV increased by 29.2% YoY, Adjusted EBITDA significantly improved by 160.6% YoY HONG KONG, March 21, 2024 /PRNewswire/ — Yeahka Limited (“Yeahka” or the “Company,” Stock Code: 9923.HK), a leading payment-based technology platform in China, is pleased to announce its annual results for the twelve months ended December 31, […]

HEADFIRST GROUP AND IMPELLAM GROUP JOIN FORCES TO BECOME A GLOBAL LEADER IN STEM, DIGITAL AND IT TALENT, MANAGED SERVICES AND HR TECH

LONDON, March 21, 2024 /PRNewswire/ — HeadFirst Group and Impellam Group today announced that they have joined forces to become one of the world’s leading STEM talent and Managed Service Providers with a distinctive HR tech platform for professionals. The expanded group has €8 billion spend under management, 2,100 expert colleagues, and over 75,000 professionals […]

HEADFIRST GROUP AND IMPELLAM GROUP JOIN FORCES TO BECOME A GLOBAL LEADER IN STEM, DIGITAL AND IT TALENT, MANAGED SERVICES AND HR TECH

LONDON, March 21, 2024 /PRNewswire/ — HeadFirst Group and Impellam Group today announced that they have joined forces to become one of the world’s leading STEM talent and Managed Service Providers with a distinctive HR tech platform for professionals. The expanded group has €8 billion spend under management, 2,100 expert colleagues, and over 75,000 professionals […]

100% CBR! FDA Granted ODD to Biostar Pharma’s Utidelone Capsule (UTD2) for the Treatment of Gastric Cancer

SAN FRANCISCO, March 21, 2024 /PRNewswire/ — Biostar Pharma, Inc., the U.S. subsidiary of Beijing Biostar Pharmaceuticals Co., Ltd. which is a synthetic biology driven biopharma company focusing on the development and commercialization of innovative oncology drugs, announced today that their key pipeline product UTD2 (utidelone capsule) had been granted an Orphan Drug Designation (ODD) by […]

HanAll Biopharma Reports Full-Year 2023 Financial Results and Provides Business Update

Full-year 2023 net revenue reaches 135 billion KRW, driven by strong sales growth. R&D momentum persisted with promising developments in anti-FcRn antibodies HL161ANS and batoclimab, positioning them as potentially best-in-class treatments for lgG-mediated autoimmune diseases. Anticipates the initiation of tanfanercept Phase 3 VELOS-4 study in dry eye disease in the first half of 2024 and top-line data […]

Biosion to Present Three Posters at the 2024 AACR Meeting

NEWARK, Del. and NANJING, China, March 21, 2024 /PRNewswire/ — Biosion, a global, clinical-stage biotechnology company, today announced upcoming presentations of pre-clinical data for its oncology pipeline assets, including BSI-111, an anti-CD16a monoclonal antibody, BSI-730, a HER2/PD-L1 bispecific antibody and BSI-093, an anti-BTN3A monoclonal antibody at the American Association for Cancer Research (AACR) Annual Meeting to […]

Strong Growth of Production Continues with Remarkable Cost Control and Financial Performance

– CNOOC Limited Announced Its 2023 Annual Results HONG KONG, March 21, 2024 /PRNewswire/ — CNOOC Limited (the “Company”, SEHK: 00883 (HKD Counter) and 80883 (RMB Counter), SSE: 600938) announced today its 2023 annual results for the year ended December 31, 2023. Accelerating reserves and production growth, new records are set Improving quality and efficiency, effective […]

1 2,103 2,104 2,105 2,335